Charles River Laboratories International, Inc. reported an insider sale by James C. Foster involving the company’s common stock. The Form 4 covers a transaction dated June 29, 2026, and was filed on July 1, 2026. Foster sold 75,000 shares of Charles River Laboratories common stock at a price of $225 per share. The reported sale price implies gross proceeds of approximately $16.875 million, before any commissions, taxes, or other transaction costs. The transaction is described as a sale of common stock and would typically be reported on Form 4 using transaction code “S” for an open-market or private sale, though the provided filing text does not show the transaction table in full. The filing includes an explanatory note stating that the sale was made pursuant to a Rule 10b5-1 trading plan adopted by Foster on March 6, 2026. Such plans allow insiders to establish prearranged trading instructions at a time when they are not in possession of material nonpublic information, providing an affirmative defense against claims that later trades were made on the basis of inside information. The excerpt provided does not state Foster’s remaining beneficial ownership after the sale, nor does it list any option exercises, vesting events, derivative securities transactions, or indirect holdings. The filing was signed by James C. Foster on June 30, 2026.